Pharming (PHAR) Total Debt (2019 - 2026)
Pharming (PHAR) posted Total Debt of $93.4 million for Q1 2026, up 0.72% on a QoQ basis from $92.7 million in Q4 2025, and up 11.38% year-over-year from $83.8 million in Q1 2025.
Pharming (PHAR) Total Debt (2019 - 2026) Analysis & Trends
Pharming's Total Debt history runs 8 years deep, the most recent figure standing at $93.4 million for Q1 2026.
- Quarterly Total Debt rose 11.38% year-over-year to $93.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93.4 million (up 11.38% YoY) and the FY2025 annual result came in at $92.7 million, up 168.72% from the prior year.
- Total Debt was $93.4 million for Q1 2026 at Pharming, up from $92.7 million in the prior quarter.
- Across five years, Total Debt topped out at $135.7 million in Q1 2022 and bottomed at -$134.9 million in Q3 2024.
- A 5-year average of $71.3 million and a median of $92.7 million in 2025 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2023 — Total Debt surged 49227.2% — and 2024, when it slumped 204.01%.
- Pharming's Total Debt stood at $1.8 million in 2022, then advanced by 3.17% to $1.8 million in 2023, then surged by 132.73% to $4.2 million in 2024, then soared by 2084.19% to $92.7 million in 2025, then grew by 0.72% to $93.4 million in 2026.
- Business Quant data shows PHAR's Total Debt at $93.4 million in Q1 2026, $92.7 million in Q4 2025, and $93.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | 93.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.39 Mn |
| Dec 31, 2025 | 92.72 Mn |
| Sep 30, 2025 | 93.14 Mn |
| Jun 30, 2025 | 91.27 Mn |
| Mar 31, 2025 | 83.85 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Sep 30, 2024 | -134.93 Mn |
| Jun 30, 2024 | 87.32 Mn |
| Mar 31, 2024 | 134.89 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 129.73 Mn |
| Jun 30, 2023 | 134.18 Mn |
| Mar 31, 2023 | 133.58 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 263,005.00 |
| Jun 30, 2022 | 128.39 Mn |
| Mar 31, 2022 | 135.73 Mn |
| Dec 31, 2021 | 306,179.25 |
| Sep 30, 2021 | 141.35 Mn |
| Jun 30, 2021 | 145.63 Mn |